Literature DB >> 1960998

Tricuspid valvulectomy without replacement. Twenty years' experience.

A Arbulu1, R J Holmes, I Asfaw.   

Abstract

Since September 1970, we have operated on 55 patients with intractable right-sided endocarditis. All patients were addicted to heroin. Fifty-three underwent tricuspid valvulectomy without replacement and in addition two had pulmonic valve excision. Twenty-four patients (49%) returned to their drug addiction. Six patients (11%) required prosthetic heart valve insertion 2 days to 13 years later for medically refractory right-sided heart failure, and four of these died. Overall, 16 patients (29%) died, six (11%) within 45 days after the tricuspid valvulectomy. One (2%) of these deaths was related to the operation and five were due to uncontrollable infection. Ten (18%) deaths occurred 9 months to 13 years after the tricuspid valvulectomy. Nine were due to drug addiction and one to progressive right ventricular failure 2 months after prosthetic heart valve insertion and 10 years after the initial valve removal. Of the 39 patients who are alive, 37 (67%) have not required prosthetic heart valve insertion. From our observations we reached the following conclusions: (1) Drug addiction is a recurrent and lethal disease. Among these patients, tricuspid valvulectomy without replacement is the operation of choice for the management of intractable right-sided endocarditis; (2) after tricuspid valvulectomy without replacement, only six of 55 patients (11%) had required prosthetic heart valve insertion to control medically refractory right-sided heart failure; (3) in a small percentage of patients the absence of the tricuspid valve may lead to severe and permanent impairment of right ventricular function.

Entities:  

Mesh:

Year:  1991        PMID: 1960998

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Giant vegetation mimicking cardiac tumor in tricuspid valve endocarditis after catheter ablation.

Authors:  M H Song; M Usui; A Usui; T Watanabe; Y Ueda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

Review 2.  Surgical management of tricuspid stenosis.

Authors:  Marisa Cevasco; Prem S Shekar
Journal:  Ann Cardiothorac Surg       Date:  2017-05

3.  Cusp commissuroplasty for tricuspid valve endocarditis.

Authors:  Yoshiharu Hamanaka; Norimasa Mitsui; Shinji Hirai; Mitsuhiro Isaka; Taira Kobayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

4.  Tricuspid anterior leaflet replacement with autologous pericardium and polytetrafluoroethylene chordae, followed by edge-to-edge repair.

Authors:  Raúl García-Rinaldi
Journal:  Tex Heart Inst J       Date:  2007

Review 5.  Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.

Authors:  Lluis Asmarats; Maurizio Taramasso; Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

Review 6.  The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Christos Mihos; Kasra Shaikhrezai; Christophe Acar; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12

7.  Tricuspid valve surgery in implantable cardiac electronic device-related endocarditis: Repair or replace?

Authors:  Mehmet Çakıcı; Evren Özçınar; Çağdaş Baran; Fatih Gümüş; Mustafa Serkan Durdu; Mustafa Bahadır İnan; Sadık Eryılmaz; Ahmet Rüçhan Akar
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

8.  Spinal Anesthesia for Emergent Abdominal Surgery in a Patient With a Tricuspid Valvectomy: A Case Report.

Authors:  Katherine Henderson Harold; Michael Webster
Journal:  A A Pract       Date:  2018-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.